Zonisamide (Zonegran): a new adjunctive antiepileptic therapy

The latest antiepileptic drug, Zonisamide (Zonegran), is currently licensed for the adjunctive treatment of partial and secondary generalised seizures in adults. Here, the authors consider its efficacy and safety and also discuss the possibility of the drug having efficacy across a range of seizure types. Copyright © 2006 Wiley Interface Ltd